Literature DB >> 35829941

NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases.

Jin Wang1,2,3, Simeng Chen1,2,3, Min Liu1,2,3, Min Zhang4, Xiaoyi Jia5,6,7.   

Abstract

NIMA-related kinase 7 (NEK7) is a serine/threonine kinase, which is the smallest one in mammalian NEK family. At present, many studies have reported that NEK7 has a physiological role in regulating the cell cycle and promoting the mitotic process of cells. In recent years, an increasing number of studies have proposed that NEK7 is involved in the activation of the NLRP3 inflammasome. Under normal conditions, NEK7 is in a low activity state, while under pathological conditions, NEK7 is abnormally expressed and therefore plays a key role in the progression of multiple tumors and chronic inflammatory diseases. This review will concentrate on the mechanism of NEK7 participates in the process of mitosis and regulates the activation of NLRP3 inflammasome, the aberrant expression of NEK7 in a variety of tumors and chronic inflammatory diseases, and some potential inhibitors, which may provide some new ideas for the treatment of diverse tumors and chronic inflammatory diseases associated with NEK7.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Chronic inflammatory diseases; Mitosis; NEK7; NLRP3 inflammasome; Tumors

Mesh:

Substances:

Year:  2022        PMID: 35829941     DOI: 10.1007/s10787-022-01026-7

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   5.093


  74 in total

1.  Nek7 kinase accelerates microtubule dynamic instability.

Authors:  Sivan Cohen; Adva Aizer; Yaron Shav-Tal; Amiel Yanai; Benny Motro
Journal:  Biochim Biophys Acta       Date:  2013-01-08

2.  Frequent alterations in the expression of serine/threonine kinases in human cancers.

Authors:  Maria Capra; Paolo Giovanni Nuciforo; Stefano Confalonieri; Micaela Quarto; Marco Bianchi; Manuela Nebuloni; Renzo Boldorini; Francesco Pallotti; Giuseppe Viale; Mikhail L Gishizky; Giulio F Draetta; Pier Paolo Di Fiore
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

3.  Nek9 is a Plk1-activated kinase that controls early centrosome separation through Nek6/7 and Eg5.

Authors:  M Teresa Bertran; Sara Sdelci; Laura Regué; Joseph Avruch; Carme Caelles; Joan Roig
Journal:  EMBO J       Date:  2011-06-03       Impact factor: 11.598

4.  A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases.

Authors:  Christopher Belham; Joan Roig; Jennifer A Caldwell; Yumi Aoyama; Bruce E Kemp; Michael Comb; Joseph Avruch
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

5.  Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.

Authors:  Franz G Bauernfeind; Gabor Horvath; Andrea Stutz; Emad S Alnemri; Kelly MacDonald; David Speert; Teresa Fernandes-Alnemri; Jianghong Wu; Brian G Monks; Katherine A Fitzgerald; Veit Hornung; Eicke Latz
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

6.  RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor.

Authors:  Yun Chen; Hongbin He; Bolong Lin; Yun Chen; Xianming Deng; Wei Jiang; Rongbin Zhou
Journal:  Cell Mol Immunol       Date:  2021-05-10       Impact factor: 22.096

7.  EK7 Regulates NLRP3 Inflammasome Activation and Neuroinflammation Post-traumatic Brain Injury.

Authors:  Yuhua Chen; Jiao Meng; Fangfang Bi; Hua Li; Cuicui Chang; Chen Ji; Wei Liu
Journal:  Front Mol Neurosci       Date:  2019-08-29       Impact factor: 5.639

8.  Expression of the NEK7/NLRP3 inflammasome pathway in patients with diabetic lower extremity arterial disease.

Authors:  HuaiQiu Cai; Peng Wang; Bo Zhang; XiaoQiu Dong
Journal:  BMJ Open Diabetes Res Care       Date:  2020-12

9.  NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling.

Authors:  Xueliang Chen; Ganglei Liu; Yuanyuan Yuan; Guotao Wu; Shalong Wang; Lianwen Yuan
Journal:  Cell Death Dis       Date:  2019-12-02       Impact factor: 8.469

10.  Micro-ribonucleic acid-23a-3p prevents the onset of type 2 diabetes mellitus by suppressing the activation of nucleotide-binding oligomerization-like receptor family pyrin domain containing 3 inflammatory bodies-caused pyroptosis through negatively regulating NIMA-related kinase 7.

Authors:  Hongye Chang; Hongjuan Chang; Tuanjie Cheng; Garrick D Lee; Xiaoping Chen; Kunqing Qi
Journal:  J Diabetes Investig       Date:  2020-11-13       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.